Chemocare.com
Care During Chemotherapy and Beyond

References

  • Abeloff, M. D., Armitage, J. O., Lichter, A. S., & Niederhuber, J. E.    
    (Eds.). (2000). Clinical Oncology (2nd ed.). New York: Churchill Livingstone.
  • Ahles, T., Saykin, A., Furstenberg, C., & et.al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20(2), 485-493.
  • Albright, A., & Valente, S. (1998). Depression and suicide. In R. Carroll-Johnson, et. al. (Ed.), Psychosocial nursing care along the cancer continuum (pp. 153-165). Pittsburgh, PA: Oncology Nursing Press.
  • American Cancer Society: Sexuality and cancer for the woman who has cancer and her partner. (2001) Publication #4657.
  • American Cancer Society: Sexuality and cancer for the man who has cancer and his partner. (2001) Publication #4658.
  • Berg, D. (2001). Diarrhea. In J. M. Yasko (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5th ed., pp. 109-130). West Conshohocken, PA: Menicus Health Care Communication.
  • Boyle, D. (2001). Psychosocial issues. In E. Lin (Ed.), Advanced practice in oncology nursing (pp. 213-232). Philadelphia: WB Saunders.
  • Brietbart, W. (2002). Depression. In K. Kuebler & P. Esper (Eds.), Palliative practice from a-z (pp. 85-88). Pittsburgh, PA: Oncology Nursing Press Press.
  • Briscoe, K. (1989). Optimal management of nausea and vomiting in clinical oncology. Oncology, 3(8 Supplement), 11-15.
  • Carroll-Johnson, R. M., Gorman, L. M., & Bush, N. J. (Eds.). (1998). Anxiety and the cancer experience. Pittsburgh, PA: Oncology Nursing Press.
  • The Cleveland Clinic Foundation. For your information: home instructions for management of nausea. (1995).
  • Conrad KJ. (2001). Cutaneous reactions. In Yasko JM (Ed.), Nursing Management of Symptoms Associated with Chemotherapy (5th ed.).
  • Constipation protocol. (1995). Cleveland Clinic Foundation: Triage protocols for the oncology nurse help line program.
  • Cope, D. (2001). Exploring the relationship between cognitive function and chemotherapy. Clinical Journal of Oncology Nursing, 5(5), 233-234.
  • Costabel, U., & King, T. E. (2001). International consensus statement on idiopathic pulmonary fibrosis. European Respiratory Journal, 17(2), 163-167.
  • Couillard-Getreuer DL, & Lutgen Heery M. (1994). Protective mechanisms: skin. In Gross J & Libey Johnson B (Eds.), Handbook of Oncology Nursing (2nd ed., pp. 421-463). Boston, MA: Jones & Bartlett.
  • Fabian, C. J., Molina, R., & Slavik, M. (1990). Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Investigational New Drugs, 8(1), 57-63.
  • Health Information. (2002). Retrieved May 9, 2003, from http://www.nei.nih.gov/health/.
  • Gacsedi, R. A. (2002). Massage therapy for patients with cancer. Clinical Journal of Oncology Nursing, 6(1), 52-54.
  • Gordon, K. B., Tajuddin, A., & Guitart, J. (1995). Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer, 75(8), 2169-2173.
  • Gross, J., & Johnson, B. L. (Eds.). (1998). Handbook of oncology nursing. London: Jones and Bartlett Publishers International Publications.
  • Harsch, R. (2002). Preventing infection during your chemotherapy treatment. Georgia-Pacific health smart institute association for professionals in infection control and epidemiology.
  • Hoffman, R., Benz, E. J., Shattil, S. J., Furie, B., Cohen, H. J., Silberstein, L. E., et al. (Eds.). (2000). Hematology: basic principles and practice, 3rd edition. New York: Churchill Livingstone.
  • Hussein MA, Wood L, Saluan MA, & et al. (1998). Efficacy of pyridoxine to ameliorate cutaneous toxicity associated with doxil abstract # 4143. Paper presented at the American Society of Hematology.
  • ImmuCyst® product information. (2002). Retrieved May 8, 2003, from http://www.immucyst.com/product.html
  • Itano, J., & Taoka, K. (Eds.). (1998). Core curriculum for oncology nursing (3rd ed.). Philadelphia PA: W.B Saunders Co.
  • Karlowicz, K. (Ed.). (1995). Urologic nursing; principles and practice. Philadelphia, PA: WB Saunders Co.
  • King, T. E., et. al. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). American Journal of respiratory critical care medicine, 161(2), 646-664.
  • Lee A, & Thomson J. (1999). Drug-induced skin reactions. Pharmaceutical Journal, 262, 357-362.
  • Lexi-Drugs online. (2002, 3/18/03). Retrieved May 5, 2003, from http://www.crlonline.com
  • Living with glaucoma. (2002). Retrieved May 9, 2003, from http://www.glaucoma.org/
  • Lubejko, B. G., & Sartorius, S. E. (1993). Nursing considerations in paclitaxel (Taxol®) administration. Seminars in Oncology, 20(4, Supplement 3), 26-30.
  • Lynch, M. P. (2000). Depression in the cancer patient. Nurse Practioner SIG(Nov), 4-5.
  • Malpas, J., Bergsagel, D., & Kyle, A. (Eds.). (1998). Myeloma biology and management (2nd ed.). New York: Oxford university press.
  • MD Consult: A resource for clinicians. (2003, 1/2/2003). Retrieved May 8, 2003, from http://home.mdconsult.com
  • Meek, P. M., et. al. (1999). Dyspnea. Mechanisms, assessment and management: a consensus statement. American Thoracic Society. American Journal of respiratory critical care medicine, 159(1), 321-340.
  • Mellors, R. C. (8/27/2002). Immunopathology; hypersensitivity reactions. Retrieved May 8, 2003, from http://www.med.cornell.edu/education.
  • Merideth, P. V., & Horan, N. M. (Eds.). (2000). Adult primary care. Philadelphia: WB Saunders Co.
  • Mortimer J, & Anderson I. (1990). Weekly fluorouracil and high-dose leucovorin: efficacy and treatment of cutaneous toxicity. Cancer Chemotherapy and Pharmacology, 26, 449-452.
  • Mosby's GenRx. (2001, 1/2/2003). Retrieved May 8, 2003, from http://home.mdconsult.com
  • Our bodies, ourselves for the new century: A book by and for women  (Comprehensive book on women's health and sexuality) Boston Women's Health Book Collective. (1998). New York: Touchstone Books.
  • PEG-INTRON®
    (peginterferon alfa-2b) Powder for Injection. (2002). Retrieved May 9, 2003, from http://www.pegintron.com/
  • Pike, K. (2001). Hand-foot syndrome. Oncology Nursing Forum, 28(10), 1519-1520.
  • Pisarnthanarax, N., & Duvic M. (2002). Dermatologic complications of cancer chemotherapy. In JF Holland & E. Frei (Eds.), Cancer Medicine (pp. 2271-2278). Hamilton, Ontario: BC Decker Inc.
  • PM Meek, & et. al. (1999). Dyspnea: mechanisms, assessment and management: a consensus statement American Thoracic Society. American Journal of Respiratory Critical Care Medicine, 159(1), 321-340.
  • Preparing for your treatment with BEXXAR® : A patient's guide to the BEXXAR® therapeutic regimen for non-Hodgkin's lymphoma, Patient resource pamphlet. (2003).  The GlaxoSmithKline Group of Companies and Corixa Corporation.
  • Questions and Answers About Taxotere®for Injection Concentrate. (2002). Retrieved May 9, 2003, from http://www.aventis-us.com.
  • Recommendations for the use of antiemetics. (2002, 2002). Retrieved May 9, 2003, from http://www.asco.org/ac/1,1003,_12-002032-00_18-0010772-00_19-0010774-00_20-001,00.asp
  • Seller, R. (Ed.). (2000). Differential diagnosis of common complaints. Philadelphia: WB Saunders Co.
  • Schover, L. R. (1997). Sexuality and fertility after cancer. New York: John Wiley & Sons.
  • Schwartz, S., & Plawecki, H. (2002). Consequences of chemotherapy on the sexuality of patients with lung cancer. Clinical Journal of Oncology Nursing, 6(4).
  • Self Help for Hard of Hearing People. (2002, 4/11/03). Retrieved May 9, 2003, from http://www.shhh.org
  • Shelton, B. K., & Turnbough, L. (1996). Flu-like syndrome. In S. Groenwald (Ed.), Cancer Symptom Management (pp. 59-71). Boston, MA: Jones and Bartlett.
  • Sherry VW. (2001). Taste alterations among patients with cancer. Clinical Journal of Oncology Nursing, 6(2), 73-77.
  • Skeel, R. (Ed.). (1999). Handbook of cancer chemotherapy. Philadelphia: Lippincott, Williams & Wilkins.
  • Specific Information for the Health Professional. (2003, May 7, 2003). Retrieved May 8, 2003, from http://www.atsdr.cdc.gov
  • Spencer, P. (2002). Anxiety. In K. Kuebler & P. Esper (Eds.), Palliative practice from a - z (pp. 23-26). Pittsburgh, PA: ONS Press.
  • St Marie, B. (2000). Anxiety. In D. H. Camp-Sorrell, R, (Ed.), Clinical manual for the oncology practice nurse (pp. 133-134). Pittsburgh, PA: ONS Press.
  • Stoller, J. K., Ahmad, M., & Longworth, D. L. (Eds.). (2002). Intensive review of internal medicine (3rd ed.). Philadelphia PA: Lippincott, Williams and Wilkins.
  • Tierney, L. M., McPhee, S. J., & Papadakis, M. A. (Eds.). (2001). Current medical diagnosis and treatment (40th ed.). Stanford, CT: Appleton and Lange.
  • Triozzi, P., & Laszlo, J. (1990). Recent advances in the control of nausea and vomiting. Primary Care & Cancer.
  • Uphold, C. R., & Graham, M. V. (Eds.). (1999). Clinical guidelines in adult health (5th ed.). Gainesville FL: Barmarrae Books.
  • USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. (1995). MMWR, 44, RR-8.
  • Uthman, E. O. (1996, 9/16/2001). Interpretation of lab test profiles. Retrieved May 8, 2003, from http://mededucation.bjmu.edu.cn.
  • Viale, P., & Mister, S. (2001). Utilization of medical-assistance programs for medically uninsured patients: one public teaching hospital's experience. Clinical Journal of Oncology Nursing, 5(6), 247-252.
  • Voss, M. A. B., & Wilkes, G. M. (1999). Neurotoxicities. American Journal of Nursing, Oncology Nursing Update, 20-23.
  • Weihofen, D., & Marino, C. (1998). The cancer survival cookbook. New York: John Wiley & Sons.
  • Weiss PA, & O'Rourke M. (1999). Cutaneous manifestations of cancer and cancer treatment. American Journal of Nursing (April Supplement), 13-16.
  • Wilkes, G. M. (1996). Neurological disturbances. In S. Groenwald (Ed.), Cancer Symptom Management (pp. 323-330). Boston, MA: Jones and Bartlett.
  • Wilkes, G. M., Ingwersen, & Barton-Burke (Eds.). (2002). Oncology Nursing Drug Handbook. Boston, MA: Jones and Bartlett.
  • Wilkinson, K. (2001). Irinotecan hydrochloride. Clinical Journal of Oncology Nursing, 5(4), 179.
  • Woodruff, R. (1997). Gastrointestinal. In Pharmacia & Upjohn (Eds.), Symptom control in advanced cancer (pp. 18-21). Melbourne.
  • Yarbro, C. H., Frogge, M. H., Goodman, M., & Groenwald, S. L. (Eds.). (1999). Cancer symptom management (5th ed.). Boston, MA: Jones and Barlett.
  • Zilbergeld, B. (1999). The new male sexuality: The truth about men, sex and pleasure. New York: Bantam Books.

Chemocare.com is designed to provide the latest information about chemotherapy to patients and their families, caregivers and friends. For information about the 4th Angel Mentoring Program visit www.4thangel.org